A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance
- 4 February 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 27 (8), 2266-2276
- https://doi.org/10.1158/1078-0432.ccr-20-3882
Abstract
Purpose: Radiation-induced cardiotoxicity is a significant concern in thoracic oncology patients. However, the basis for this disease pathology is not well-characterized. We developed a novel mouse model of radiation-induced cardiotoxicity to investigate pathophysiologic mechanisms and identify clinically targetable biomarkers of cardiac injury. Experimental Design: Single radiation doses of 20, 40, or 60 Gy were delivered to the cardiac apex of female C57BL/6 mice aged 9-11 weeks, with or without adjacent lung tissue, using conformal radiation therapy (RT). Cardiac tissue was harvested up to 24 weeks post-RT for histologic analysis. Echocardiography and Technetium-99 sestamibi single photon emission computed tomography (SPECT) at 8 and 16 weeks post-RT were implemented to evaluate myocardial function and perfusion. Mouse cardiac tissue and mouse and human plasma were harvested for biochemical studies. Results: Histopathologically, RT resulted in perivascular fibrosis 8 and 24 (p<0.05) weeks post-RT. Apical perfusion deficits on SPECT and systolic and diastolic dysfunction on echocardiography 8 and 16 weeks post-RT were also observed (p<0.05). Irradiated cardiac tissue and plasma showed significant increases in placental growth factor (PlGF), interleukin-6, and tumor necrosis factor-alpha (TNFa) compared to non-radiated matched controls, with greater increases in cardiac cytokine levels when RT involved lung. Human plasma showed increased PlGF (p=0.021) and TNFa (p=0.036) levels post-thoracic RT. Conclusions: We developed and characterized a pathophysiologically relevant mouse model of radiation-induced cardiotoxicity involving in situ irradiation of the cardiac apex. The model can be used to integrate radiomic and biochemical markers of cardiotoxicity to inform early therapeutic intervention and human translational studies.Keywords
Other Versions
Funding Information
- University of Pennsylvania Diabetes Research Center (P30-DK19525)
- NIH (TL1TR001880)
- NIH (R01 HL 118018)
- NIH (R01 HL148272)
This publication has 36 references indexed in Scilit:
- Preclinical Research into Basic Mechanisms of Radiation-Induced Heart DiseaseCardiology Research and Practice, 2011
- Radiation-Related Heart Disease: Current Knowledge and Future ProspectsInternational Journal of Radiation Oncology*Biology*Physics, 2010
- Elevation of Plasma TGF-β1 During Radiation Therapy Predicts Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer: A Combined Analysis From Beijing and MichiganInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Prevention and Treatment of Functional and Structural Radiation Injury in the Rat Heart by Pentoxifylline and Alpha-TocopherolInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary SyndromesJournal of the American College of Cardiology, 2006
- Early Variations of Circulating Interleukin-6 and Interleukin-10 Levels During Thoracic Radiotherapy Are Predictive for Radiation PneumonitisJournal of Clinical Oncology, 2005
- The role of radiotherapy in cancer treatmentCancer, 2005
- Placental Growth Factor Promotes Atherosclerotic Intimal Thickening and Macrophage AccumulationCirculation, 2005
- Myocardial perfusion scintigraphy: the evidenceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Potential molecular targets for manipulating the radiation responseInternational Journal of Radiation Oncology*Biology*Physics, 1997